BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 16880483)

  • 1. Psychotic symptom and cannabis relapse in recent-onset psychosis. Prospective study.
    Hides L; Dawe S; Kavanagh DJ; Young RM
    Br J Psychiatry; 2006 Aug; 189():137-43. PubMed ID: 16880483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The temporal dynamics of relationships between cannabis, psychosis and depression among young adults with psychotic disorders: findings from a 10-month prospective study.
    Degenhardt L; Tennant C; Gilmour S; Schofield D; Nash L; Hall W; McKay D
    Psychol Med; 2007 Jul; 37(7):927-34. PubMed ID: 17288638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reasons for cannabis use in psychosis.
    Schofield D; Tennant C; Nash L; Degenhardt L; Cornish A; Hobbs C; Brennan G
    Aust N Z J Psychiatry; 2006; 40(6-7):570-4. PubMed ID: 16756582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabis use and childhood trauma interact additively to increase the risk of psychotic symptoms in adolescence.
    Harley M; Kelleher I; Clarke M; Lynch F; Arseneault L; Connor D; Fitzpatrick C; Cannon M
    Psychol Med; 2010 Oct; 40(10):1627-34. PubMed ID: 19995476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal association of cannabis use with symptoms in individuals at clinical high risk for psychosis.
    Corcoran CM; Kimhy D; Stanford A; Khan S; Walsh J; Thompson J; Schobel S; Harkavy-Friedman J; Goetz R; Colibazzi T; Cressman V; Malaspina D
    Schizophr Res; 2008 Dec; 106(2-3):286-93. PubMed ID: 18809298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabis use and age at onset of symptoms in subjects at clinical high risk for psychosis.
    Dragt S; Nieman DH; Schultze-Lutter F; van der Meer F; Becker H; de Haan L; Dingemans PM; Birchwood M; Patterson P; Salokangas RK; Heinimaa M; Heinz A; Juckel G; Graf von Reventlow H; French P; Stevens H; Ruhrmann S; Klosterkötter J; Linszen DH;
    Acta Psychiatr Scand; 2012 Jan; 125(1):45-53. PubMed ID: 21883099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of cannabis use expectancies on cannabis use and psychotic symptoms in psychosis.
    Hides L; Kavanagh DJ; Dawe S; Young RM
    Drug Alcohol Rev; 2009 May; 28(3):250-6. PubMed ID: 18608451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabis use is not associated with the development of psychosis in an 'ultra' high-risk group.
    Phillips LJ; Curry C; Yung AR; Yuen HP; Adlard S; McGorry PD
    Aust N Z J Psychiatry; 2002 Dec; 36(6):800-6. PubMed ID: 12406123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is cannabis an anti-antipsychotic? The experience in psychiatric intensive care.
    Isaac M; Isaac M; Holloway F
    Hum Psychopharmacol; 2005 Apr; 20(3):207-10. PubMed ID: 15682431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptomatology and neuropsychological functioning in cannabis using subjects at ultra-high risk for developing psychosis and healthy controls.
    Korver N; Nieman DH; Becker HE; van de Fliert JR; Dingemans PH; de Haan L; Spiering M; Schmitz N; Linszen DH
    Aust N Z J Psychiatry; 2010 Mar; 44(3):230-6. PubMed ID: 20180725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective.
    Hambrecht M; Häfner H
    Aust N Z J Psychiatry; 2000 Jun; 34(3):468-75. PubMed ID: 10881971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabis--psychosis pathway independent of other types of psychopathology.
    Ferdinand RF; van der Ende J; Bongers I; Selten JP; Huizink A; Verhulst FC
    Schizophr Res; 2005 Nov; 79(2-3):289-95. PubMed ID: 16125368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabis use in patients with a first psychotic episode and subjects at ultra high risk of psychosis: impact on psychotic- and pre-psychotic symptoms.
    Machielsen M; van der Sluis S; de Haan L
    Aust N Z J Psychiatry; 2010 Aug; 44(8):721-8. PubMed ID: 20636193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabis psychosis and acute schizophrenia. a case-control study from India.
    Basu D; Malhotra A; Bhagat A; Varma VK
    Eur Addict Res; 1999 Jun; 5(2):71-3. PubMed ID: 10394036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Motivational interviewing for cannabis users with psychotic disorders].
    Bonsack C; Montagrin Y; Favrod J; Gibellini S; Conus P
    Encephale; 2007 Oct; 33(5):819-26. PubMed ID: 18357854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association between early cannabis use and psychotic-like experiences in a community adolescent sample.
    Hides L; Lubman DI; Buckby J; Yuen HP; Cosgrave E; Baker K; Yung AR
    Schizophr Res; 2009 Jul; 112(1-3):130-5. PubMed ID: 19428219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of cannabis use in men with and without psychosis.
    Green B; Kavanagh DJ; Young RM
    Addict Behav; 2007 Dec; 32(12):2879-87. PubMed ID: 17544588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-illness cannabis use and the early course of nonaffective psychotic disorders: associations with premorbid functioning, the prodrome, and mode of onset of psychosis.
    Compton MT; Broussard B; Ramsay CE; Stewart T
    Schizophr Res; 2011 Mar; 126(1-3):71-6. PubMed ID: 21036542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people.
    Henquet C; Krabbendam L; Spauwen J; Kaplan C; Lieb R; Wittchen HU; van Os J
    BMJ; 2005 Jan; 330(7481):11. PubMed ID: 15574485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of cannabis and psychosis vulnerability in daily life: an experience sampling test study.
    Verdoux H; Gindre C; Sorbara F; Tournier M; Swendsen JD
    Psychol Med; 2003 Jan; 33(1):23-32. PubMed ID: 12537033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.